Literature DB >> 22457940

Susceptibility of allogeneic mice to teratocarcinoma 402AX.

S Ostrand-Rosenberg1, T M Rider, A Twarowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 22457940     DOI: 10.1007/bf01572595

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  16 in total

1.  Studies on transplantable testicular teratomas of strain 129 mice.

Authors:  L C STEVENS
Journal:  J Natl Cancer Inst       Date:  1958-06       Impact factor: 13.506

2.  Cell surface antigens of totipotent mouse teratocarcinoma cells grown in vivo: their relation to embryo, adult, and tumor antigens.

Authors:  M J Dewey; J D Gearhart; B Mintz
Journal:  Dev Biol       Date:  1977-02       Impact factor: 3.582

3.  Interaction of peanut agglutinin, a lectin specific for nonreducing terminal D-galactosyl residues, with embryonal carcinoma cells.

Authors:  Y Reisner; G Gachelin; P Dubois; J F Nicolas; N Sharon; F Jacob
Journal:  Dev Biol       Date:  1977-11       Impact factor: 3.582

4.  Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc.

Authors:  G D Snell; R J Graff; M Cherry
Journal:  Transplantation       Date:  1971-06       Impact factor: 4.939

5.  Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody.

Authors:  E A Boyse; E Stockert; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

6.  Human teratoma cells share antigens with mouse teratoma cells.

Authors:  S Ostrand-Rosenberg; M Edidin; M A Jewett
Journal:  Dev Biol       Date:  1977-11       Impact factor: 3.582

7.  Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen.

Authors:  J Forman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

Authors:  P R Avner; W F Dove; P Dubois; J A Gaillard; J L Guénet; F Jacob; H Jakob; A Shedlovsky
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

9.  Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture.

Authors:  K Artzt; P Dubois; D Bennett; H Condamine; C Babinet; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

10.  Cell surface antigens of a mouse testicular teratoma. Identification of an antigen physically associated with H-2 antigens on tumor cells.

Authors:  L R Gooding; M Edidin
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more
  5 in total

1.  Overt expression of H-2 serotypes on EC cells is not necessary for host rejection.

Authors:  L J Maher; W F Dove
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

2.  Growth conditions of F9 embryonal carcinoma cells affect the degree of DNA methylation.

Authors:  R P Erickson; S Ferrucci; B Rahe; M P Rosenberg; D Morello
Journal:  Mol Biol Rep       Date:  1984-12       Impact factor: 2.316

3.  Strong teratocarcinoma transplantation loci, Gt-1 and Gt-2, flank H-2.

Authors:  A Shedlovsky; L J Clipson; J L VandeBerg; W F Dove
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Resistance to 402AX teratocarcinoma involves immunity to minor histocompatibility antigens.

Authors:  S Ostrand-Rosenberg; V Clements
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  Teratocarcinoma transplantation antigens are encoded in the H-2 region.

Authors:  L L Johnson; L J Clipson; W F Dove; J Feilbach; L J Maher; A Shedlovsky
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.